Compare BHM & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHM | TELA |
|---|---|---|
| Founded | 2022 | 2012 |
| Country | United States | United States |
| Employees | N/A | 218 |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.7M | 31.4M |
| IPO Year | 2022 | 2019 |
| Metric | BHM | TELA |
|---|---|---|
| Price | $8.88 | $0.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $15.00 | $2.00 |
| AVG Volume (30 Days) | 4.0K | ★ 283.3K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | ★ 4.54% | N/A |
| EPS Growth | N/A | ★ 37.59 |
| EPS | N/A | ★ N/A |
| Revenue | $68,734,000.00 | ★ $80,275,000.00 |
| Revenue This Year | N/A | $10.23 |
| Revenue Next Year | N/A | $14.26 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 36.88 | 15.84 |
| 52 Week Low | $8.05 | $0.50 |
| 52 Week High | $13.59 | $1.81 |
| Indicator | BHM | TELA |
|---|---|---|
| Relative Strength Index (RSI) | 40.79 | 45.92 |
| Support Level | $8.11 | $0.67 |
| Resistance Level | $9.55 | $0.96 |
| Average True Range (ATR) | 0.32 | 0.07 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 0.00 | 25.77 |
Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The company has two reportable segments, consisting of Residential Communities, which derives maximum revenue; and Scattered Single-family homes.
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.